SB

Shrikant Bhaskarrao Patil

Active Director Director DIN 09828042
DIN 09828042 First appointment Dec 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shrikant Bhaskarrao Patil

Data last updated:

Shrikant Bhaskarrao Patil is a Director at Sinope Pharmaceutical Private Limited (since 2022). The company operates in Pharma.

DIN 09828042
Primary Designation Director
Industry Pharma
First Appointment 17 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Dec 20222022Active

Board colleagues of Shrikant Bhaskarrao Patil

NameDINCompanyDesignation
Rupali Mohandas Dhake09828041Sinope Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sinope Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Shrikant Bhaskarrao Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shrikant Bhaskarrao Patil

Shrikant Bhaskarrao Patil currently holds 1 directorship: Sinope Pharmaceutical Private Limited (Director, since 17 Dec 2022).

Shrikant Bhaskarrao Patil was first appointed on 17 Dec 2022 as Director at Sinope Pharmaceutical Private Limited.

The current boards of Shrikant Bhaskarrao Patil's companies include Rupali Mohandas Dhake (Sinope Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available